
Join to View Full Profile
1801 W Taylor StSuite 3DChicago, IL 60612
Phone+1 312-413-5569
Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2017
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2010 - 2013
Saint Louis University School of MedicineClass of 2010
Certifications & Licensure
IL State Medical License 2017 - 2026
MA State Medical License 2014 - 2017
TX State Medical License 2012 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Association of Pancreas Volume With Adverse Clinical Outcomes.Philip Thomas, Celestin Missikpode, Omar Garcia Martinez, Ashish Verma, Runqi Zhao
Journal of the American Heart Association. 2025-11-04 - Advancing Noninvasive Imaging to Quantify Kidney Fibrosis: Hidden in Plain Sight.Momen Abbasi, Anand Srivastava
American Journal of Kidney Diseases. 2025-10-01 - Management of Kidney Disease with Sickle Cell Disease.Momen Abbasi, Anand Srivastava, Santosh L Saraf
Journal of the American Society of Nephrology. 2025-10-01
Press Mentions
UIC Researchers to Lead Large-Scale Noninvasive Study of Chronic Kidney DiseaseJuly 8th, 2025
In CKD, Proteinuria Provides Many Kinds of Prognostic ValueJuly 1st, 2025
GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II DiabetesNovember 13th, 2024- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









